Keya Medical, a leading medical AI technology company, was recognized as one of the top 50 Global Healthcare Technology Companies at the 2020 World Innovators Meet (WIM) conference held By Equal Ocean in Beijing from December 9-11.
The conference, which was held to promote the concept that “Technology and Innovation Connects the World,” brought together Nobel Prize winners and global speakers from Asia, Africa, Europe, and North America to share their insights on innovation and how they strive to further promote equality through technology. During WIM2020, the WIM Committee announced the winners of the World Innovation Awards. Leading companies and industry experts were chosen based on analyses of industry and investment research, along with reputable research reports.
Keya Medical was recognized as one of the Top 50 Global Healthcare Technology Companies because of its numerous achievements in the medical AI industry in China over the past five years. Keya Medical’s deep learning-based CT-FFR product, DeepVessel FFR, was the first AI-empowered Class III medical device approved by the National Medical Products Administration (NMPA) in China. The company is also the second company in the world that has obtained the necessary approvals to commercialize AI-empowered medical devices in China, the United States, and the European Union.
About Keya Medical
Keya Medical Technology Co. Ltd. is a medical technology company that is dedicated to the development and commercialization of deep learning-based medical devices for disease diagnosis and treatment with a goal to revolutionize the medical device industry. Since 2016, the company has developed solutions for specialities including cardiology, radiology, neurology, pathology, and surgery. Today, Keya Medical collaborates with 728 hospitals to improve care delivery on a global scale. To learn more about Keya Medical, follow us on LinkedIn and Twitter.